SCHEMBL23778261

SCHEMBL23778261

CCN(C(=O)O)[C@@H]1CCN(C2CCC(C#N)(c3ccccc3)CC2)C1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.53
KDM1A O60341 1/20 0.44
CCR5 P51681 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KCNH2 Q12809 1/20 0.43
USP30 Q70CQ3 1/20 0.43
HSD11B1 P28845 1/20 0.42
HRH3 Q9Y5N1 3/20 0.41
OPRD1 P41143 1/20 0.41
ALDH1A1 P00352 1/20 0.39
OPRM1 P35372 1/20 0.39
CHRM4 P08173 1/20 0.39
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23778460 0.91 CYP2D6 (0.58) CYP2D6KDM1ACCR5MEN1KMT2A
SCHEMBL23778377 0.91 CYP2D6 (0.58) CYP2D6KDM1ACCR5MEN1KMT2A
SCHEMBL23778224 0.90 CYP2D6 (0.44) CYP2D6KDM1ACCR5MEN1KMT2A
SCHEMBL23778241 0.90 CYP2D6 (0.50) CYP2D6KDM1ACCR5MEN1KMT2A
SCHEMBL23778237 0.90 CYP2D6 (0.44) CYP2D6KDM1ACCR5MEN1KMT2A
SCHEMBL23778327 0.90 CYP2D6 (0.50) CYP2D6KDM1ACCR5MEN1KMT2A
SCHEMBL23778421 0.88 CCR5 (0.47) CYP2D6CCR5KCNH2USP30HRH3
SCHEMBL23778384 0.88 CYP2D6 (0.46) CYP2D6CCR5MEN1KMT2AKCNH2
SCHEMBL23778326 0.88 KMT2A (0.48) CYP2D6CCR5KMT2AKCNH2OPRD1
SCHEMBL23778319 0.86 HSD11B1 (0.45) CYP2D6KDM1ACCR5KCNH2USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109996792-B Heterocyclic compounds having activity as modulators of muscarinic M1 and/or M4 receptors in the treatment of CNS diseases and pain 赫普泰雅治疗有限公司 2023-02-17 CN claimed
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP claimed